Search Results (271)

Pancreatic neuroendocrine neoplasms (PanNENs) are a heterogeneous group of tumors characterized by variable biological behavior and frequent overexpression of somatostatin receptors, making them ideal candidates for theranostic approaches. Over the past two decades, advances in molecular imaging and peptide receptor radionuclide therapy (PRRT) have fundamentally transformed the diagnosis and management of advanced PanNENs, establishing nuclear medicine as a central component of precision oncology. This review provides a comprehensive overview of the evolving role of theranostics in PanNENs, with particular emphasis on recent developments in nuclear medicine and radiation-based precision medicine. We discuss the biological foundation of molecular imaging, current clinical evidence supporting PRRT, and emerging strategies for personalized radionuclide therapy based on quantitative imaging, patient selection, and individualized dosimetry. Furthermore, we highlight next-generation radiopharmaceuticals, including somatostatin receptor antagonists and α-emitting radionuclides, as well as novel diagnostic tracers that are expanding the scope of theranostic applications. The review also examines the growing impact of artificial intelligence, radiomics, and computational modeling in image analysis, treatment planning, and adaptive radionuclide therapy. Finally, we discuss future perspectives toward adaptive precision theranostics, in which molecular imaging, multi-omics integration, advanced dosimetry, and artificial intelligence converge to support dynamic, patient-specific treatment strategies. Continued technological innovation and multidisciplinary collaboration are expected to further establish theranostics as a cornerstone of personalized management for patients with PanNENs. Full article

The Hwange Mining Area, located in the Mid-Zambezi Karoo Basin in northwestern Zimbabwe, is a major centre for coal mining, processing, and thermal power generation. This study evaluates the ecological and public health risks associated with these activities by characterising radionuclide (²²⁶Ra, ²³²Th, ⁴⁰K) activity concentrations in coal and surrounding soils using Hyper-Pure Germanium (HPGe) gamma spectrometry. Samples were collected from four locations, as follows: Hwange Colliery Company (underground and open-cast mines), Zambezi Gas open-cast operations, residential areas, and the Zimbabwe Power Company (ZPC) thermal power station. Radionuclide concentrations were measured using Hyper-Pure Germanium (HPGe) gamma spectrometry. Mean activity concentrations in coal were low at both mining sites (Hwange Colliery: ²²⁶Ra 16 ± 5.3 Bq/kg), ²³²Th 14 ± 5.7 Bq/kg), (⁴⁰K 51 ± 8.8 Bq/kg) and Zambezi Gas (²²⁶Ra 9.80 ± 2.3 Bq/kg), ²³²Th (11 ± 3.3 Bq/kg), ⁴⁰K (43 ± 26 Bq/kg), well below UNSCEAR world coal averages. In contrast, soils from residential areas): ²²⁶Ra (36 ± 15 Bq/kg), ²³²Th (36 ± 12 Bq/kg) and ⁴⁰K (220 ± 80 Bq/kg), and the ZPC power station (²²⁶Ra 47 ± 8.6 Bq/kg, ²³²Th (42 ± 10 Bq/kg), and ⁴⁰K 230 ± 92 Bq/kg, showed markedly elevated concentrations, consistent with the accumulation of coal-combustion by-products such as fly ash. Radiological hazard indices remained within internationally accepted limits at all sites, as follows: radium equivalent (Raeq) ranged from 29 ± 6.7 Bq/kg (Zambezi Gas) to 120 ± 18 Bq/kg (ZPC), well below the 370 Bq/kg safety ceiling, while external and internal hazard indices (H_ex, H_in) remained below unity throughout, peaking at 0.32 and 0.46, respectively, at ZPC. Annual effective dose equivalents (AEDE) ranged from 16 ± 3.8 to 69 ± 10 μSv/year, the latter (ZPC) representing approximately 7% of the ICRP public dose limit of 1 mSv/year. Excess lifetime cancer risk (ELCR) values ranged from 5.56 × 10⁻⁵ (Zambezi Gas) to 2.42 × 10⁻⁴ (ZPC), remaining below the global average outdoor reference of 0.29 × 10⁻³ but reaching approximately 83% of this reference at ZPC and 71% in residential areas. These findings indicate that, while coal mining activities in Hwange contribute minimally to environmental radioactivity, coal combustion at the ZPC thermal power station is the dominant driver of elevated radionuclide concentrations and radiological indices in the surrounding environment, with residential soils reflecting the same enrichment pathway. Although no immediate radiological hazard was identified at any location, the comparatively higher indices at ZPC and in nearby residential areas underscore the need for continuous environmental monitoring, strengthened regulatory control, and targeted radiation protection strategies to safeguard workers and nearby communities. Full article

Background: Patient-specific targeted radionuclide therapy (TRT) requires consideration not only of administered activity but also of the spatial distribution of radiopharmaceutical uptake and radionuclide-specific energy deposition. This study developed a voxel-based computational workplan to compare ¹⁷⁷Lu, ¹⁶¹Tb and ⁹⁰Y, together with hybrid radionuclide models, using patient-specific PSMA PET-derived tumour activity distributions. Methods: PSMA PET/CT data from 20 patients with prostate cancer, comprising 10 ¹⁸F-PSMA and 10 ⁶⁸Ga-PSMA examinations, were processed to obtain 2285 quality-filtered lesions. Radionuclide-specific dose-point kernels (DPKs) were generated in water using OpenGATE and applied to voxel-wise lesion activity distributions to reconstruct absorbed-dose maps. Kernel characteristics were evaluated using radial energy-containment metrics, and ¹⁷⁷Lu, representing ¹⁶¹Tb simulations, was subjected to grid-convergence testing and external comparison with a published DPK. Lesion dosimetry was assessed using Dmean, D90, D95, equivalent uniform dose (EUD) and tumour control probability (TCP), with uncertainty quantified using patient-cluster bootstrap confidence intervals. Kinetic sensitivity and diagnostic tracer subgroup analyses were additionally performed. Results: The study showed that ¹⁶¹Tb produced the highest median lesion-level Dmean, D90, D95 and EUD at 182.79, 136.28, 132.07 and 148.53 Gy, respectively, with a median TCP of 0.981. Corresponding values for ¹⁷⁷Lu were 141.33, 105.42, 102.10 and 114.78 Gy (TCP 0.930), while ⁹⁰Y produced lower local dose metrics but the broadest radial dose distribution, consistent with its longer-range β-particle crossfire. ¹⁶¹Tb remained the highest-ranking radionuclide across the investigated kinetic cases and within both diagnostic tracer subgroups. Hybrid ¹⁶¹Tb/⁹⁰Y kernels provided a controllable compromise between localised energy deposition and extended crossfire; a 70:30 model increased central dose localisation while retaining an R90 and R95 of 6 and 7 mm, respectively. Grid-convergence and published-DPK comparisons supported the numerical adequacy of the kernel methodology. Radionuclide emission characteristics substantially influence the transformation of heterogeneous tumour uptake into spatial absorbed-dose distributions. Within this model, ¹⁶¹Tb provided the strongest overall lesion-level dosimetric performance, whereas the extended range of ⁹⁰Y may offer complementary crossfire for selected bulky or heterogeneous lesions. Conclusions: The findings support phenotype-informed radionuclide comparison and provide a computational basis for investigating hybrid strategies. However, the absolute dose estimates and proposed radionuclide combinations remain model-based and require validation using serial therapeutic imaging, heterogeneous patient-specific dosimetry and normal-organ dose constraints before clinical translation. Full article

Modern separation and purification technologies increasingly require materials that combine high selectivity, chemical robustness, and long-term operational stability without compromising mechanical performance. Radiation- and radical-induced graft copolymerization addresses this need by generating radical sites on polymer backbones and introducing tailored functional groups through subsequent monomer grafting. Retention of bulk properties, however, depends on controlling radiation dose, polymer structure, oxygen, and irradiation conditions so that grafting is favored over chain scission, crosslinking, and embrittlement. This review critically examines recent grafting strategies for gas and liquid separation, water treatment, radionuclide management, and resource recovery. It relates radical generation, graft growth, structural control, and functional-group chemistry to material performance and process optimization. Attention is given to radiation-induced grafting and its integration with controlled radical polymerization, especially reversible addition–fragmentation chain-transfer polymerization, to regulate graft density, chain length, and architecture. Composite and interfacial approaches are also evaluated. The review discusses the requirements and remaining barriers to practical translation, including dose optimization, long-term stability, regeneration, reproducibility, scalability, and the need for techno-economic and life-cycle assessments. Full article

This mini-review is intended to show how multimodal imaging could be developed from prototypes and proofs of concept by controlling the nanoscale for improved resolution of life science imaging for broad applications such as bioassays, early diagnoses and further applications. It intends to afford the presentation of multimodal approaches for imaging and bioimaging uses with potential applications to biological media. The application of multimodal nanoemitters provides enhanced bioimaging through the generation of various targeted and well-defined signals. Radionuclides and luminescent emitters were considered in the discussion for improved and enhanced signaling. In this manner, we intended to show the increase in the power of information by collecting varied optical signal–matter interactions. This could be important for Positron Emission Tomography and Computed Tomography (PET-CT), Fluorescence Tomography (FT), and other new modes of imaging contemplating the incorporation of nanotechnology. In the context of the design of new multimodal energy modes, key examples were shown from the literature, where the interactions of different energy modes could lead to enhanced and improved signaling. Electromagnetic fields and nanoplasmonics are involved in these different energy modes involving varied quantum particle interactions with modified properties. In this regard, multimodal imaging has experienced developments in nanoemitters and nanobiolabeling to track biomolecular events and targeted cells. A large quantity of research output actually focuses on nano- and quantum emissions. However, there are not as many studies dealing with enhanced emissions or laser emissions coupled with radionuclide emitters. A non-classical form of light emission, considering varied luminescent phenomena as well as further quantum signaling, showed interesting and high-impact perspectives when combined with nuclear emissions. This is the case for current trends focusing on innovative single-cell analysis. For example, the characterization and diagnosis of cells where the targeting of antibody–antigen interactions is required, providing light and energy from different sources to produce different details and imaging resolutions, has been noted. These are potential approaches that could be developed through various strategies targeting life science applications. In this regard, this article puts forward a discussion focused on nanotechnology contemplating radio-pharmacy and enhanced nanoemitters. Full article

Accumulation of radionuclides in crop products can pose public health risks. Parameters of ¹³⁷Cs root uptake by maize were investigated at four growth stages, from leaf development to ripening (June–September), in the post-Chernobyl area of the Plavsk radioactive hotspot (the Tula region of Russia). It was established that the chernozem of the agrosystem still contains about 180 kBq ¹³⁷Cs m⁻². Seasonal trends of ¹³⁷Cs activity concentrations in above- and belowground parts of maize differ appreciably. In aerial parts, the ¹³⁷Cs accumulation rate increases as vegetative organs develop from June to July, then drops when generative organs appear in August. In the belowground biomass, the ¹³⁷Cs content increases with the growth of fine roots, which serve as relative concentrators of the radionuclide. However, at all stages of growth, radionuclide transfer to maize occurs with low intensity. It does not directly depend on changes in biomass, dry matter content, or ⁴⁰K content, and only slightly relates to the ash content. The transfer factor is estimated to be 6.2 × 10⁻³ for cob kernels (grain) and 3.8 × 10⁻² for stems and leaves, which corresponds to the IAEA-recommended values and ensures acceptable levels of ¹³⁷Cs accumulation in crop products produced in the territory. Full article

Photocatalytic fuel cells (PFCs) integrate photocatalysis with fuel cell technology to enable simultaneous wastewater treatment and energy recovery. This review examines recent advances in PFC cathode materials, focusing on design strategies, reduction mechanisms, and applications. The cathode governs electron transfer and interfacial reactions, including oxygen reduction (4e⁻ or 2e⁻ pathways), direct pollutant electroreduction, and oxidant activation for radical generation. Cathodic materials including transition metal oxides/sulfides, carbon-based materials, metal–organic frameworks and their derivatives, are systematically summarized, evaluating their respective activities, stabilities and costs. Rational design via heterojunction engineering, defect modulation, and composite construction enables tunable reaction pathways and enhanced performance. Furthermore, representative applications are reviewed, with particular attention to the effective degradation of organic pollutants, and reduction of heavy metals and radionuclides in PFCs. Future efforts should prioritize long-term stability, scalable fabrication, and multi-functional cathode integration. Full article

Phosphogypsum (PG), a gypsum-rich by-product of wet-process phosphoric acid production, is increasingly considered for land application because it can supply calcium and sulfur and alleviate constraints such as sodicity, subsoil acidity, and vegetation establishment limitations. However, PG may also contain residual acidity, soluble salts, fluoride, heavy metals, and naturally occurring radionuclides, creating multiple exposure pathways. This critical review distinguishes direct PG evidence from gypsum or sulfate analogue evidence, life cycle assessment/material flow analysis evidence, and risk control studies. It evaluates PG land application according to receiving soil conditions, diagnosed constraints, exposure pathways, and environmental safety boundaries. The strongest evidence supports use in diagnosed sodic and saline–sodic soils, whereas applications in Al-toxic acid subsoils, flooded paddy systems, contaminated or degraded soils, and non-food vegetated systems require conditional assessment. PG should therefore be treated as a context-specific management option rather than an unrestricted disposal route. By linking waste valorization with soil demand, source quality, exposure control, and long-term monitoring, the proposed framework contributes to sustainability by integrating circular resource use with soil health, water protection, food/feed safety, and risk-informed governance, while helping to prevent the transfer of environmental burdens across ecosystems or generations. Full article

With the rapid development of nuclear medicine, the safe and sustainable management of medical radioactive wastewater has become an increasingly critical challenge at the interface of radiation protection and environmental engineering in China. Current management practices primarily focus on end-of-pipe treatment, whereas systematic frameworks integrating wastewater generation, collection, treatment, monitoring, and risk-informed discharge remain insufficient. In this narrative review, we systematically examine the complete management chain of medical radioactive wastewater, from generation to discharge, by evaluating source reduction strategies, available treatment technologies, and international regulatory frameworks, while also summarizing the requirements for whole-process monitoring and occupational radiation protection. We characterize the pollution profiles and discharge loads associated with major medical radionuclides, assess the applicability of different treatment technologies under various operational scenarios, and analyze key differences between Chinese and international regulatory approaches. Based on these analyses, we first establish a hierarchical decision matrix for treatment process selection considering hospital classification and site-specific constraints, and subsequently propose a six-tier end-to-end management framework integrating source reduction, source characterization, multi-constraint process selection, tiered treatment intensification, multi-level quality monitoring, and risk-informed discharge. This framework promotes a paradigm shift in medical radioactive wastewater management from conventional end-of-pipe treatment toward integrated full-chain governance, providing theoretical insights and practical guidance for the standardized, refined, and sustainable management of medical radioactive wastewater in China. Full article

Cancer remains one of the leading causes of morbidity and mortality worldwide despite advances in molecular oncology and targeted therapeutics. The growing demand for precision medicine has accelerated the development of radiotheranostics, an emerging paradigm that integrates molecular imaging and targeted radionuclide therapy. In parallel, medicinal chemistry continues to generate structurally diverse small-molecule scaffolds capable of modulating key oncogenic pathways. Increasing evidence indicates that certain chemical scaffolds possess intrinsic properties that extend beyond conventional anticancer activity and support their translation into radiotheranostic applications. This review examines major scaffold classes driving contemporary anticancer drug discovery, including thiosemicarbazones, heterocyclic compounds, metal-based agents, hybrid molecules, and multifunctional platforms. Particular attention is given to the structural features governing biological activity, target selectivity, metal coordination, and radiolabeling potential. The review further highlights the mechanistic convergence between scaffold-mediated anticancer effects and radionuclide-induced cytotoxicity, emphasizing shared pathways involving DNA damage, oxidative stress, inhibition of DNA repair, and modulation of oncogenic signaling. Based on these observations, a scaffold-centered framework for radiotheranostic development is proposed, with perspectives on hybrid molecular design, copper-based theranostic systems, and artificial intelligence-assisted ligand discovery. By integrating medicinal chemistry, molecular oncology, and nuclear medicine, this review outlines structural principles that may facilitate the rational design of next-generation precision anticancer agents and radiotheranostic platforms. Full article

Olfactory neuroblastoma (ONB), also known as esthesioneuroblastoma, is a rare malignant tumor arising from the olfactory epithelium of the sinonasal tract. Surgery combined with radiotherapy remains the standard treatment for localized disease, whereas chemotherapy is mainly used in advanced or recurrent cases. However, recurrent and metastatic ONB continues to present major therapeutic challenges, and traditional staging and histological grading systems cannot fully explain the marked differences in clinical behavior among patients. The primary objective of this review is to summarize recent advances in the molecular pathology, tumor microenvironment (TME), and emerging targeted therapeutic strategies in ONB. Emerging genomic and transcriptomic studies suggest that ONB comprises biologically heterogeneous tumors with distinct molecular and transcriptional programs associated with proliferation, neuroendocrine differentiation, angiogenesis, and stromal remodeling. Furthermore, we explore the increasing attention directed toward the TME, including immune-cell infiltration, angiogenic signaling, and immune checkpoint expression, which may influence therapeutic response. These molecular findings have generated interest in several potential targeted treatment strategies, including peptide receptor radionuclide therapy (PRRT), anti-angiogenic therapy, epigenetic-targeted therapy, immunotherapy, and DNA-damage-response-targeted approaches. Ultimately, although the current evidence remains limited because of the rarity of the disease, novel therapeutic strategies for ONB are emerging. In addition to summarizing the current landscape, this review discusses the translational challenges and future directions for precision oncology and biomarker-driven therapy, aiming to provide insights for improving individualized patient management. Full article

A large quantity of irradiated nuclear graphite has been generated worldwide and must be managed as radioactive waste. In Germany, the final disposal of irradiated graphite (i-graphite) remains challenging due to limited knowledge of the radionuclide inventory and strict regulatory constraints. The presence of gamma-emitting radionuclides raises concerns regarding radiation exposure during handling, for example, in reactor decommissioning operations. Decontamination processes are therefore being investigated to enable the selective removal of key radionuclides, with the dual objective of facilitating waste acceptance and enabling the potential reuse of treated graphite in technical applications. This study focuses on the selective removal of volatile gamma-emitting radionuclides using a thermal treatment approach. In this work, a steam-assisted thermal treatment was applied to i-graphite samples from the Forschungsreaktor Jülich 2 (FRJ-2). The influence of key process parameters, including temperature, treatment duration, and relative humidity, was systematically investigated. The results show complete removal of ⁶⁰Co and ¹³⁷Cs, while partial removal of approximately 40% was achieved for ^152,154,155Eu and ²⁴¹Am. No release of ¹³³Ba was observed. These findings demonstrate the potential of high-temperature treatment as an effective method for reducing the radionuclide inventory of irradiated graphite, thereby contributing to improved waste management strategies and safer handling during decommissioning. Full article

Auger-electron-emitting radionuclides offer a distinctive route toward molecular-scale radiotherapy because their biological effects depend primarily on the nanoscale location of the decay event rather than on long-range tissue penetration. This review examines Auger-emitting radionuclides from a radiopharmaceutical perspective, integrating decay-associated physicochemical processes, cellular dosimetry, subcellular targeting, and translational relevance. We first discuss the physical determinants of Auger radiotoxicity, including Auger and Coster–Kronig electrons, internal-conversion electrons, local ionization density, and possible molecular consequences of highly localized Auger cascades. Cellular S values are used to illustrate how the same radionuclide can produce markedly different absorbed doses depending on whether activity is localized in the nucleus, cytoplasm, cell membrane, or neighboring cells. Iodine-125 incorporated into DNA as [¹²⁵I]iododeoxyuridine ([¹²⁵I]IUdR) remains the classical reference model for maximal Auger-mediated radiotoxicity. However, this direct DNA-incorporation model should not be generalized to receptor-targeted radiopharmaceuticals, which usually achieve indirect nuclear, chromatin-associated, perinuclear, membrane-associated, or vesicular localization rather than incorporation into DNA. These alternative source–target geometries may also produce biologically relevant effects, but they are mechanistically distinct from DNA-proximal [¹²⁵I]IUdR decay. Particular attention is given to iodine-123 versus iodine-125, the influence of physical half-life and specific activity, the interpretation of terbium-161 as a hybrid β⁻/internal-conversion/Auger emitter, and the overlooked radiobiological relevance of diagnostic Auger emitters such as technetium-99m, indium-111, and gallium-67. We conclude that Auger-emitter radiopharmaceuticals cannot be ranked by electron yield or decay scheme alone. Their therapeutic or toxicological relevance emerges from the integration of decay-associated physicochemical processes, cellular source–target dosimetry, intracellular trafficking, retention, and the temporal realization of dose delivery. Full article

⁹⁰Sr is a representative anthropogenic radionuclide, widely released into the environment through atmospheric nuclear tests, nuclear accidents, and routine operations of nuclear facilities, resulting in long-term residual contamination in soils worldwide. Its long half-life, high mobility, and chemical similarity to calcium make it easy to enter the food chain through the soil–plant system, thereby posing a persistent threat to ecosystems and human health. Conventional physical and chemical remediation approaches are often costly, ecologically disruptive, and inefficient for large-scale applications, highlighting an urgent need for sustainable, in situ strategies. Moreover, existing knowledge on ⁹⁰Sr behavior has largely been generated from isolated studies, lacking an integrated framework to guide remediation efforts. This review summarizes the migration mechanisms of ⁹⁰Sr in the soil–plant system and the main factors influencing its transport and accumulation. In soil, the migration of ⁹⁰Sr is jointly controlled by soil texture and mineral composition, competing cations, organic matter, soil pH, and moisture, with cation exchange acting as the main immobilization mechanism. Plant uptake and accumulation of ⁹⁰Sr show distinct inter- and intra-species differences, and the distribution generally follows the pattern of vegetative organs > reproductive organs. This process is regulated by root activity, transpiration, and competition with Ca²⁺ transport channels. Agronomic practices such as liming, deep plowing, and balanced fertilization can effectively reduce the phytoavailability of ⁹⁰Sr by promoting ion competition and modifying the rhizosphere environment. Meanwhile, phytoremediation offers a promising green approach for the remediation of contaminated soils. Overall, this review provides a theoretical basis and scientific reference for the risk management and bioremediation of ⁹⁰Sr in soil–plant systems. Full article

Yttrium-90 (⁹⁰Y) is a pivotal pure beta-emitting radionuclide extensively employed in the targeted therapy of malignant tumors, such as hepatocellular carcinoma and lymphoma. The ⁹⁰Sr-⁹⁰Y generator system represents the most effective method for producing no-carrier-added (NCA) ⁹⁰Y to meet escalating clinical demands. However, safe clinical application necessitates the stringent separation of its parent isotope, ⁹⁰Sr, which poses significant radiotoxicological risks due to its long half-life and bone-seeking behavior. This review comprehensively summarizes recent advances in solid-phase adsorbent materials developed for the high-efficiency separation of Y³⁺ and Sr²⁺. We systematically analyze the design strategies, molecular recognition mechanisms, and performance evaluation metrics of various functional systems. Key materials discussed include extraction chromatography (EXC) resins based on organophosphorus extractants, diglycolamide (DGA) derivatives, and crown ethers, as well as inorganic ion exchangers such as antimony-based materials, manganese oxides, and zeolite-like molecular sieves. Special attention is given to composite modification strategies, including silica-based and polymer-matrix composites, and metal doping techniques aimed at enhancing radiation resistance, acid stability, and Sr-Y separation factors (SF). Finally, we provide an outlook on the future development of next-generation ⁹⁰Sr-⁹⁰Y generator materials, highlighting the imperative of transitioning from idealized simulated environments to robust, field-ready applications. Full article